An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

AURYXIA®

Drug Information Related Patent
Hold Company
KERYX BIOPHARMS
Learn More
Dosage and Administration
TABLET;ORAL
Specification
EQ 210MG IRON
Indication
AURYXIA® is used in chronic kidney disease dialysis patients with hyperphosphatemia and non-dialysis chronic kidney disease iron deficiency anemia.
Use
Instructions for Use
API
FERRIC CITRATE
API Structure
We Supply
FERRIC CITRATE
Note:

In-house Standard
Facility GMP
DMF

null
Note:

null

null
Note:

null

Drug Patent
Patent NoExpiration Date
103000392030/7/21
77678512024/2/18
80934232026/4/21
82992982024/2/18
83386422024/2/18
86098962024/2/18
87542572024/2/18
87542582024/2/18
88469762024/2/18
89013492024/2/18
90503162024/2/18
93281332024/2/18
93871912030/7/21
97574162024/2/18
API Patent
Patent NoExpiration Date
80934232026/4/21
82992982024/2/18
83386422024/2/18
86098962024/2/18
87542572024/2/18
87542582024/2/18
88469762024/2/18
89013492024/2/18
90503162024/2/18
93281332024/2/18
97574162024/2/18

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top